(61 days)
Dentin and Enamel adhesive for use with amalgam and resin based restorative materials.
Not Found
This an FDA approval letter for a device named Alloybond, which is a Dentin and Enamel adhesive. The letter mentions that the device is "substantially equivalent" to devices marketed before May 28, 1976. However, the provided document does not contain any information regarding acceptance criteria, device performance details, study design (sample sizes, data provenance, expert ground truth, adjudication methods, MRMC studies), or ground truth establishment for either test or training sets. This letter confirms approval and mentions that the device can be marketed.
Therefore, I cannot fulfill the request as the necessary information is not present in the provided text.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human figures, representing the department's focus on people and their well-being.
...
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 1 6 1998
Samantha J. Cheetham Ms. Official Correspondent Southern Dental Industries Incorporated 246 First Street, Suite 204 San Francisco, California 94105
Re : K981383 ALLOYBOND Trade Name: Regulatory Class: II KLE Product Code: March 30, 1998 Dated: Received: April 16, 1998
Dear Ms. Cheetham:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ਸ substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) requlation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action, In addition, FDA may publish further announcements concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of
{1}------------------------------------------------
Paqe 2 - Ms. Cheetham
the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A. Ulatowski
Timothy A Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
.
ന്നും
പിന്നും
വിക്ഷേത്രം
{2}------------------------------------------------
Page 1 of 1
में कि में हैं कि कि मिली है कि कि में कि कि में कि किसी की में बाद में हैं कि कि में कि कि में कि किसी की में बाद में कि में बाद में कि में कि किसी की में बाद में कि में कि
510(k) Number (if known):
Device Name:
| |
Alloybond
Indications For Use:
Dentin and Enamel adhesive for use with amalgam and resin based restorative materials.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Curres
(Division Sign-Off)
Division of Dental, Infection Control,
and General Hospital Devices
510(k) Number 1981382
OR
ারী স্বামী বা
Prescription Use: (Per 21 CFR 801.109)
Over-The-Counter Use: ________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)
§ 872.3200 Resin tooth bonding agent.
(a)
Identification. A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling.(b)
Classification. Class II.